Radiopharm Theranostics Statistics
NASDAQ: RADXHealth CareBiotechnology: Pharmaceutical PreparationsUSD
1.150.00 (0.00%)
Market open · Delayed 15 min · as of Oct 7, 4:00 PM ET
Radiopharm Theranostics by the numbers
Radiopharm Theranostics has a market capitalization of $16.8 million based on 14.59M shares outstanding. With trailing EPS of $-3.64, Radiopharm Theranostics is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 47.3% below its 50-day average and 71.4% below its 200-day average.
Average daily trading volume is 84.62K shares, or about $97,314 in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
RADX valuation vs. peer median
| Metric | RADX | Peer median | Difference |
|---|---|---|---|
| Market cap | $16.78M | $16.50M | +2% |
| Avg. volume | 84.62K | 126.37K | -33% |
Peer median across 8 companies: PTN, MRKR, NCEL, LPCN, RKTO, ALLR, NEUP, ACTU.
Valuation
- Market cap
- $16.78M
- EPS (TTM)
- $-3.64
- Shares outstanding
- 14.59M
Price and trading
- Previous close
- 1.15
- Open
- 1.18
- Day range
- 1.13 – 1.19
- 52-week range
- 1.00 – 16.25
- 52-week change
- -83.66%
- Beta
- —
- Volume
- 145
- Average volume
- 84.62K
Dividends and events
- Annual dividend
- None
Additional statistics
- Market Cap
- 16.78M
- Forward Pe
- -0.50
- Eps
- -3.64
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 16.25
- Week52 Low
- 1.00
- Avg Volume
- 84,621.00
- Shares Outstanding
- 14.59M
- Ma50
- 2.18
- Ma200
- 4.03
- Pct From52w High
- -92.92%
- Pct From52w Low
- 15.00%